2024 ASTRO Annual Meeting Post Conference Update

Thanks for stopping by our booth to learn about our latest cell-free DNA-based NGS assays in head and neck cancer.

If you weren’t able to make it to ASTRO, see what you missed below.

September 29 – October 1, 2024
Washington, DC
astro.org

Show Highlights:

  • Our cell-free HPV DNA assay received tremendous interest from radiation oncologists and researchers in the field of head and neck cancer and other HPV-associated cancers.
  • Our assay received special mention in the “Integration of HPV ctDNA Testing into Clinical Practice – Ready for Prime Time?” educational symposium as the only NGS assay available on the market.
  • Our exhibitor booth successfully featured our latest clinical trials data on utilizing cell-free HPV DNA assay in head and neck cancer.
Our team

The Sysmex Inostics Team was excited to interact with booth visitors on how our cell-free HPV DNA assay can transform treatment monitoring and surveillance for head and neck and other HPV-associated cancers.

Our booth

We showcased the high performance features of our assay – the only NGS-based cell-free HPV-DNA assay available on the market.

Interactions

We discussed current unmet needs in treatment monitoring with radiation oncologists in the field of head and neck cancer and HPV+ cancers.

Insights

We shared the latest clinical evidence on utilizing our cell-free HPV DNA NGS-based assay for improving treatment monitoring beyond imaging for head and neck cancer.

2024 ASTRO Annual Meeting Materials

Download the materials we showcased at ASTRO.